Abstract
Three recent articles are examined in which research using the double-blind randomised clinical trial, the case control study, and the quasi-cohort study is described. Understanding the advantages and disadvantages of these methods makes it easier to grasp the pneumococcal vaccine controversy and make an informed choice.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AUSTRIAN R., GOLD J. PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. Ann Intern Med. 1964 May;60:759–776. doi: 10.7326/0003-4819-60-5-759. [DOI] [PubMed] [Google Scholar]
- Austrian R. Pneumococcus: the first one hundred years. Rev Infect Dis. 1981 Mar-Apr;3(2):183–189. doi: 10.1093/clinids/3.2.183. [DOI] [PubMed] [Google Scholar]
- Austrian R. The pneumococcus at Hopkins: early portents of future developments. Johns Hopkins Med J. 1979 Jun;144(6):192–201. [PubMed] [Google Scholar]
- Broome C. V., Facklam R. R., Fraser D. W. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med. 1980 Sep 4;303(10):549–552. doi: 10.1056/NEJM198009043031003. [DOI] [PubMed] [Google Scholar]
- Clemens J. D., Shapiro E. D. Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials? Rev Infect Dis. 1984 Sep-Oct;6(5):589–600. doi: 10.1093/clinids/6.5.589. [DOI] [PubMed] [Google Scholar]
- Hirschmann J. V., Lipsky B. A. Pneumococcal vaccine in the United States. A critical analysis. JAMA. 1981 Sep 25;246(13):1428–1432. [PubMed] [Google Scholar]
- Minor D. R., Schiffman G., McIntosh L. S. Response of patients with Hodgkin's disease to pneumococcal vaccine. Ann Intern Med. 1979 Jun;90(6):887–892. doi: 10.7326/0003-4819-90-6-887. [DOI] [PubMed] [Google Scholar]
- Shapiro E. D., Berg A. T., Austrian R., Schroeder D., Parcells V., Margolis A., Adair R. K., Clemens J. D. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991 Nov 21;325(21):1453–1460. doi: 10.1056/NEJM199111213252101. [DOI] [PubMed] [Google Scholar]
- Simberkoff M. S., Cross A. P., Al-Ibrahim M., Baltch A. L., Geiseler P. J., Nadler J., Richmond A. S., Smith R. P., Schiffman G., Shepard D. S. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Nov 20;315(21):1318–1327. doi: 10.1056/NEJM198611203152104. [DOI] [PubMed] [Google Scholar]
- Sims R. V., Steinmann W. C., McConville J. H., King L. R., Zwick W. C., Schwartz J. S. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 1988 May;108(5):653–657. doi: 10.7326/0003-4819-108-5-653. [DOI] [PubMed] [Google Scholar]